Biomarkers to enable personalised care and improve outcomes in high risk pregnancy
- Submitting institution
-
King's College London
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Summary impact type
- Health
- Request cross-referral to
- -
- Is this case study continued from a case study submitted in 2014?
- No
- Underpinning research subjects
-
- Clinical Sciences
- Paediatrics And Reproductive Medicine
- Public Health And Health Services
3. References to the research
5. Sources to corroborate the impact
Additional contextual information
Grant funding
| Grant number |
Value of grant |
| 12/25/03 |
£1,700,962 |
| OPP1086183 |
£727,261 |
| MR/R021376/1 |
£792,857 |
| NIHR200254 |
£340,000 |
| 092993/Z/10/Z WS/2987400 |
£1,274,184 |
| n/a |
£1,926,211 |
| PB-PG-0214-33054 |
£142,628 |
| OPP1017337 |
£17,235,806 |
| n/a |
£750,000 |
| 623964 |
£183,933 |
| 12/164/16 |
£1,503,744 |
| CDRF-2013-04-026 |
£827,299 |
| 14/01/2002 |
£661,350 |
| RP-2014-05-019 |
£1,532,180 |
- Formal partners
-
- Newcastle University, Guy's and St Thomas' NHS Foundation Trust, University of Liverpool, University of Oxford, UCL University College London
- Kimberly Clinical Trials Unit, UBC University of British Columbia, Preeclampsia Foundation, University of California, San Francisco, Fundaçao Manhiça
- KLE University, Lusaka University Teaching Hospital, Ndola Central Hospital
- Imperial College London
- Guy's and St Thomas' NHS Foundation Trust, UCL University College London
- Intercept Pharmaceuticals Inc.
- University of Exeter, Fetal Medicine Foundation, Medway NHS Foundation Trust, PerkinElmer Inc., Queen Mary University of London, UCL University College London, Roche Diagnostics Ltd, BRAMHS GmbH
- Funding programmes
-
- PHOENIX - Pre-eclampsia in HOspital: Early iNductIon or eXpectant management
- CRADLE: Community blood pressure monitoring in Rural Africa: Detection of underLying pre-Eclampsia
- CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs.Expectant management in pre-eclampsia?
- NIHR Senior Investigator Award
- The role of reproductive hormone metabolites in gestational alterations in lipid and bile metabolism
- Core Funding
- Placental growth factor to Assess and diagnose hypeRtensive pRegnant wOmen: a stepped wedge Trial (PARROT)
- PRE-EMPT
- NIHR/Genomics England-funded whole genome sequencing study of 270 cases of severe ICP
- GDMICP - Gestational signal and bile acid role in the enteroinsular axis
- PITCHES
- Threatened preterm labour: development and validation of an effective risk assessment tool to improve management and care.
- Screening ProgRamme for prE-Eclampsia (SPREE)
- Improving maternal and perinatal outcomes in high-risk pregnancies
- Global research identifiers
-
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- grid.13097.3c
- Name of funders
-
- National Institute for Health Research
- Bill & Melinda Gates Foundation
- Medical Research Council
- NIHR National Institute for Health Research
- Wellcome Trust
- Tommy’s Charity
- National Institute for Health Research
- Gates Foundation
- National Institute for Health Research
- European Commission
- National Institute for Health Research
- National Institute for Health Research
- National Institute for Health Research
- National Institute for Health Research
- Researcher ORCIDs
-
- 0000-0001-5273-3132
- 0000-0001-6219-3379
- 0000-0001-5273-3132
- 0000-0003-2000-743X
- 0000-0001-5273-3132
- 0000-0001-6219-3379
- 0000-0003-2000-743X
- 0000-0002-6226-7611
- 0000-0002-6226-7611
- 0000-0003-1100-2821
- 0000-0001-5273-3132
- 0000-0001-6219-3379
- 0000-0003-4136-3070
- 0000-0002-6226-7611
- 0000-0002-6226-7611
- 0000-0001-6219-3379
- 0000-0002-6226-7611
- 0000-0003-2550-6465
- 0000-0003-3675-9978
- 0000-0001-5273-3132
- 0000-0003-2000-743X
- 0000-0002-3944-4130
- 0000-0003-1266-0711
- 0000-0001-6219-3379
